Catalyst Wire Dossier Catalyst Wire Dossier

Nanoliposomal irinotecan

irinotecan liposomal · Ipsen
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Nanoliposomal irinotecan, covering 2023-04-11 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer [Phase 2]

See pricing